[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

ANI Pharma Inc (ANIP)

ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET

PRINCETON, N.J., July 24, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the Company will release its second quarter 2026 financial results...

ANIP : 78.41 (-0.15%)
1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds

1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds

IART : 19.80 (+6.68%)
ANIP : 78.41 (-0.15%)
LH : 297.92 (+2.37%)
2 Reasons to Watch ANIP and 1 to Stay Cautious

2 Reasons to Watch ANIP and 1 to Stay Cautious

ANIP : 78.41 (-0.15%)
2 Small-Cap Stocks Worth Investigating and 1 We Brush Off

2 Small-Cap Stocks Worth Investigating and 1 We Brush Off

PAYO : 7.12 (unch)
LYFT : 14.44 (+3.00%)
ANIP : 78.41 (-0.15%)
ANI Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter

Trial court denied Company’s motion for a new trial and judgment as a matter of law for unjust enrichment ANI intends to appeal rulings to the Delaware Supreme Court and continue to seek to recover...

ANIP : 78.41 (-0.15%)
ANI Pharmaceuticals Announces Positive Six-Month Topline Data from the Phase 4 Open-Label, Single-Arm SYNCHRONICITY Trial Evaluating Fluocinolone Acetonide Intravitreal Implant in Patients with Chronic Non-Infectious Uveitis

Trial met both co-primary endpoints of mean change from baseline in BCVA letter score and mean change from baseline CST with statistical significance at 6 months The most common adverse events reported...

ANIP : 78.41 (-0.15%)
2 Value Stocks for Long-Term Investors and 1 We Avoid

2 Value Stocks for Long-Term Investors and 1 We Avoid

WK : 53.07 (+4.72%)
YELP : 25.39 (+3.63%)
ANIP : 78.41 (-0.15%)
3 of Wall Street’s Favorite Stocks to Target This Week

3 of Wall Street’s Favorite Stocks to Target This Week

GOOGL : 319.75 (+0.65%)
CRC : 53.77 (-0.88%)
ANIP : 78.41 (-0.15%)
How Is Viatris’ Stock Performance Compared to Other Healthcare Stocks?

Viatris has outperformed its industry peers over the past year, and Wall Street appears optimistic about the stock.

XLV : 162.65 (+0.75%)
VTRS : 17.33 (+0.29%)
ANIP : 78.41 (-0.15%)
2 Cash-Producing Stocks to Research Further and 1 Facing Challenges

2 Cash-Producing Stocks to Research Further and 1 Facing Challenges

CSGP : 27.85 (+2.62%)
TRU : 76.54 (+3.67%)
ANIP : 78.41 (-0.15%)

Barchart Exclusives

Before You Chase SMCI’s SpaceX Rally, Remember This Rocket Has Misfired Before
Investors should wait for the upcoming earnings report before jumping in on the margin improvement and SpaceX hype. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.